Ultimovacs ASA (OSL: ULTI)
Norway
· Delayed Price · Currency is NOK 2.740
+0.035 (1.29%)
Aug 30, 2024, 4:25 PM CET
Ultimovacs ASA Market Cap
Ultimovacs ASA has a market cap or net worth of 94.27 million as of August 30, 2024. Its market cap has decreased by -96.37% in one year.
Market Cap
94.27M
Enterprise Value
-73.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.74
Market Cap Chart
Since June 3, 2019, Ultimovacs ASA's market cap has decreased from 863.67M to 94.27M, a decrease of -89.08%. That is a compound annual growth rate of -34.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 30, 2024 | 94.27M | -97.77% |
| Dec 29, 2023 | 4.23B | 11.67% |
| Dec 30, 2022 | 3.78B | -1.98% |
| Dec 30, 2021 | 3.86B | 50.91% |
| Dec 30, 2020 | 2.56B | 134.21% |
| Dec 30, 2019 | 1.09B | 26.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.02B |
| Nordhealth AS | 2.93B |
| Nykode Therapeutics AS | 2.10B |
| Photocure ASA | 1.51B |
| Carasent ASA | 1.31B |
| ArcticZymes Technologies ASA | 969.33M |
| Hofseth BioCare ASA | 842.72M |
| Gentian Diagnostics ASA | 809.67M |